Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE:LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ: SQNM), a pioneer in non-invasive prenatal testing (NIPT) for reproductive health, today announced that they have entered into a definitive agreement and plan of merger under which LabCorp would acquire all of the outstanding shares of Sequenom in a cash tender offer for $2.40 per share, or an equity value of $302 million, which represents a total enterprise value of approximately $371 million, including net indebtedness.
Morrow Sodali is acting as Information Agent on this merger.
Click here to request documents for this deal.
Related News
Sodali & Co Appoints Emily Wei and Hasib Nasirullah as Co-Leads of Global Sustainability Practice
19 August 2025
Sodali & Co Strengthens U.S. Corporate Governance Advisory with Appointment of Matthew Vahidi as Managing Director
13 August 2025
Entering a new phase of shareholder activism
04 August 2025
APAC teams take #1 spot in Mergermarket PR Advisor Rankings
31 July 2025
Media enquiries
To contact our global experts for comments please get in touch below.
Contact us chevron_right